Teva's CGRP Migraine Med Hits a Stumbling Block Post author:Sam Post published:February 8, 2018 Post category:BioPharma It’s starting to feel like Teva can’t catch a break. Source: BioSpace You Might Also Like Sanofi Falls Short of Q3 Expectations, Terminates Phase II Lung Drug From Pipeline November 1, 2017 FDA Clears Expanded Indication for Medtronic's Freezor Xtra Cryoablation Catheter February 16, 2017 Sage Therapeutics Stock Rockets on Two Positive Phase III Trials in Postpartum Depression November 8, 2017
Sage Therapeutics Stock Rockets on Two Positive Phase III Trials in Postpartum Depression November 8, 2017
